These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823 [TBL] [Abstract][Full Text] [Related]
6. Effects of depression and Parkinson's disease on cognitive functioning. Norman S; Tröster AI; Fields JA; Brooks R J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652 [TBL] [Abstract][Full Text] [Related]
7. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Burn DJ Mov Disord; 2002 May; 17(3):445-54. PubMed ID: 12112190 [TBL] [Abstract][Full Text] [Related]
8. Drug Choices and Advancements for Managing Depression in Parkinson's Disease. Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207 [TBL] [Abstract][Full Text] [Related]
9. Depression in Parkinson's disease: diagnosis and management. Latoo J; Mistry M; Dunne FJ Br J Hosp Med (Lond); 2012 Jun; 73(6):331-4. PubMed ID: 22875323 [TBL] [Abstract][Full Text] [Related]
10. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Althaus A; Becker OA; Spottke A; Dengler R; Schneider F; Kloss M; Eggert K; Oertel WH; Dillmann U; Herting B; Classen J; Dodel R Parkinsonism Relat Disord; 2008 Dec; 14(8):626-32. PubMed ID: 18406197 [TBL] [Abstract][Full Text] [Related]
11. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737 [TBL] [Abstract][Full Text] [Related]
12. Depression in Parkinson's disease. Pharmacological characteristics and treatment. Tom T; Cummings JL Drugs Aging; 1998 Jan; 12(1):55-74. PubMed ID: 9467687 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Meco G; Bernardi S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377 [TBL] [Abstract][Full Text] [Related]
15. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review. Leentjens AF Drugs; 2011 Feb; 71(3):273-86. PubMed ID: 21319866 [TBL] [Abstract][Full Text] [Related]
16. Depression and Parkinson's disease: current knowledge. Marsh L Curr Neurol Neurosci Rep; 2013 Dec; 13(12):409. PubMed ID: 24190780 [TBL] [Abstract][Full Text] [Related]
17. [Benchmarking in patient care: depression in Parkinson's disease]. Spottke A; Schneider F; Dodel R Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798 [TBL] [Abstract][Full Text] [Related]
19. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. Smith KM; Eyal E; Weintraub D; JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207 [TBL] [Abstract][Full Text] [Related]
20. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. Calleo J; Williams JR; Amspoker AB; Swearingen L; Hirsch ES; Anderson K; Goldstein SR; Grill S; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone GM; Weiss H; Rabins P; Marsh L J Parkinsons Dis; 2013; 3(4):603-8. PubMed ID: 24275604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]